期刊
DRUG DELIVERY AND TRANSLATIONAL RESEARCH
卷 13, 期 2, 页码 378-385出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s13346-022-01232-4
关键词
Gold nanoparticles; Gold nanoconstructs; Nanomedicine; Clinical trials; Drug delivery; Photothermal therapy
Gold nanoparticles with unique physicochemical features are being investigated for therapeutic purposes. After two decades of preclinical progress, gold nanoconstructs are transitioning into clinical trials. The current consensus is to focus on specific disorders for therapeutic applications.
Gold nanoparticles display unique physicochemical features, which can be useful for therapeutic purposes. After two decades of preclinical progress, gold nanoconstructs are slowly but steadily transitioning into clinical trials. Although initially thought to be magic golden bullets that could be used to treat a wide range of diseases, current consensus has moved toward a more realistic approach, where gold nanoformulations are being investigated to treat specific disorders. These therapeutic applications are dictated by the pharmacokinetics and biodistribution profiles of gold nanoparticles. Here, we analyze the current clinical landscape of therapeutic gold nanoconstructs, discuss the shared characteristics that allowed for their transition from bench to bedside, and examine existing hurdles that need to be overcome before they can be approved for clinical use.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据